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A B S T R A C T
Background: Associations between several persistent organic pollutants (POPs) and type 2 diabetes have been
found in humans, but the relationship has rarely been investigated in the general population. The current nested
case-control study examined internal exposure to polychlorinated biphenyls (PCB) and pesticides and the in-
cidence of type 2 diabetes among participants of two population-based German cohort studies.
Methods: We retrospectively selected 132 incident cases of type 2 diabetes and 264 age- and sex-matched
controls from the CARdiovascular Living and Aging in Halle (CARLA) study (2002–2006, East Germany) and the
Cooperative Health Research in the Region of Augsburg (KORA) study (1999–2001, South Germany) based on
diabetes status at follow-up examinations in 2007–2010 and 2006–08, respectively (60% male, mean age 63 and
54 years). We assessed the association between baseline POP concentrations and incident diabetes by conditional
logistic regression adjusted for cohort, BMI, cholesterol, alcohol, smoking, physical activity, and parental dia-
betes. Additionally, we examined effect modification by sex, obesity, parental diabetes and cohort.
Results: In both cohorts, diabetes cases showed a higher BMI, a higher frequency of parental diabetes, and higher
levels of POPs. We observed an increased chance for incident diabetes for PCB-138 and PCB-153 with an odds
ratio (OR) of 1.50 (95%CI: 1.07–2.11) and 1.53 (1.15–2.04) per interquartile range increase in the respective
POP. In addition, explorative results suggested higher OR for women and non-obese participants.
Conclusions: Our results add to the evidence on diabetogenic effects of POPs in the general population, and
warrant both policies to prevent human exposure to POPs and additional research on the adverse effects of more
complex chemical mixtures.
1. Introduction
Traditional lifestyle risk factors such as physical inactivity, smoking
and obesity, are not sufficient to fully explain the current epidemic of
type 2 diabetes. Attempts to identify novel risk factors beyond the
traditional ones have mounted evidence on the contribution of en-
vironmental contaminants to the rapid rise in the incidence of type 2
diabetes. Associations between persistent organic pollutants (POPs) and
the development of type 2 diabetes have been shown for over ten years
now (Lee et al., 2006; Porta, 2006; Lee et al., 2007; Jones et al., 2008)
and several reviews (Taylor et al., 2013; Magliano et al., 2014; Ngwa
et al., 2015; Jaacks and Staimez, 2015; Yang et al., 2017; Lind and Lind,
2018) and one meta-analysis of epidemiological studies (Wu et al.,
2013) combined the findings corroborating the initial assumption.
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POPs are a class of ubiquitous environmental compounds, either
used as pesticides or generated as by-products of industrial or com-
bustion processes. Typical examples include chlorinated compounds
such as polychlorinated biphenyls (PCBs), organochlorine pesticides
and dioxins (Lee et al., 2014). Since resistant to any kind of environ-
mental degradation, POPs persist in the environment and can subse-
quently accumulate in the food chain (Grün and Blumberg, 2009). Most
POPs were banned several decades ago in many countries. Yet, humans
are still exposed to these chemicals through contaminated food, espe-
cially fatty animal products like fish, meat, and milk (Grün and
Blumberg, 2009; Verner et al., 2013). When POPs enter the human
body, they are primarily stored in adipose tissue and are slowly released
into the circulation to be eliminated over several years (Milbrath et al.,
2009).
The mechanisms that link POP exposure to diabetes are not fully
understood. Nevertheless, several pathways have been proposed in-
cluding endocrine-disrupting processes and mechanisms related to mi-
tochondrial dysfunction (Alonso-Magdalena et al., 2006; Newbold
et al., 2009; Meyer et al., 2013). While animal studies reported dele-
terious effects of POPs with respect to obesity, insulin sensitivity and
glucose absorption (Ruzzin et al., 2010; Enan and Matsumura, 1994), a
recent experimental paper suggested that chronic exposure to low doses
of POPs may increase the risk of type 2 diabetes by primarily affecting
pancreatic ß-cell function rather than insulin resistance (Lee et al.,
2017).
Though the number of epidemiological studies investigating POPs
and type 2 diabetes is already quite large, the overall evidence is still
suggestive since most of these studies were limited by either a highly
selected population, a low number of study participants and/or cross-
sectional study designs precluding the assertion of a causal relationship
(Taylor et al., 2013; Magliano et al., 2014; Ngwa et al., 2015; Yang
et al., 2017; Lind and Lind, 2018).
Several prospective studies have reported positive associations be-
tween POPs and the risk of diabetes ruling out reverse causation, yet
with inconsistent findings for individual POPs (Wu et al., 2013; Lee
et al., 2011a; Lee et al., 2010; Rignell-Hydbom et al., 2009; Turyk et al.,
2009; Vasiliu et al., 2006; Wang et al., 2008; Grice et al., 2017; Zong
et al., 2018; Turyk et al., 2015). Also, most of these studies were from
the U.S. (Wu et al., 2013; Lee et al., 2010; Turyk et al., 2009; Vasiliu
et al., 2006; Grice et al., 2017; Zong et al., 2018; Turyk et al., 2015),
based on highly exposed participants (Turyk et al., 2009; Vasiliu et al.,
2006; Wang et al., 2008; Turyk et al., 2015) or restricted to females (Wu
et al., 2013; Rignell-Hydbom et al., 2009; Zong et al., 2018) or the
elderly (Lee et al., 2011a). Therefore, the current nested case-control
study aimed to investigate the relationship between serum concentra-
tions of POPs and incident type 2 diabetes in the general population by
selecting participants of two large German population-based cohort
studies.
2. Material and methods
2.1. Study population and case definition
We combined data from two population-based cohort studies: the
CARdiovascular Disease, Living and Ageing in Halle (CARLA) and the
Cooperative Health Research in the Region of Augsburg (KORA) study.
Details on study design have been described elsewhere (Greiser et al.,
2005; Rathmann et al., 2003; Holle et al., 2005). Briefly, the CARLA
study was conducted in the urban area of Halle, Eastern Germany,
between 2002 and 2006. The 1779 participants, aged 45–83 years, were
followed-up between 2007 and 2010. Data collection included a de-
tailed standardized computer-assisted interview, self-administered
questionnaires, physical examination, and blood sampling. Incidence of
diabetes was based on a hemoglobin A1c (HbA1c) level≥ 6.5% at
follow-up (and HbA1c<6.5% at baseline), a self-reported physician's
diagnosis between the baseline and the follow-up examination, or on
newly prescribed glucose-lowering medication (ATC-Code A10). The
age- and sex-matched controls did not report having diabetes and had
normal glucose metabolism with HbA1c levels< 5.7% at both baseline
and follow-up examination.
The KORA S4 survey (1999–2001) was conducted in the region of
Augsburg, Southern Germany including a cluster-random sample of all
inhabitants of the study region of German nationality aged 25–74 years.
From the initial 4261 participants, 3080 (72%) participated in the
follow-up examination KORA F4 in 2006–2008. Data collection in-
cluded standardized computer-assisted personal interviews, self-ad-
ministered questionnaires, physical examination, and blood sampling.
A standard 75 g oral glucose tolerance test (OGTT) was performed
among S4 and F4 participants who did not report having diabetes; in
KORA S4 the OGTT was only conducted in participants aged 55 years
and older. According to the 1999/2006 WHO criteria (WHO, 2006)
normal glucose metabolism was defined as fasting glucose< 6.1mmol/
l and 2 h glucose< 7.8mmol/l and diabetes as fasting glucose
≥7.0mmol/l or 2 h glucose ≥11.1mmol/l. All incident diabetes cases
at baseline (S4) did report being nondiabetic, did not use glucose-
lowering medication (ATC-Code A10), had HbA1c levels< 6.3% and
had neither fasting nor 2 h glucose in the diabetic range if an OGTT had
been conducted. At follow-up (F4) they had either 1) HbA1c levels
≥6.3% and a self-reported diabetes diagnosis that occurred later than
one year after S4 and that could be validated by the responsible phy-
sician or medical chart review, or 2) HbA1c levels> 6.5% and OGTT-
diagnosed diabetes. The age- and sex-matched controls did not report
having diabetes and had normal glucose metabolism with HbA1c le-
vels< 5.7% and according to OGTT if an OGTT had been conducted at
both baseline and follow-up examination.
The current study population consisted of 77 incident cases of dia-
betes and 154 age- and sex-matched controls with normal glucose
metabolism from CARLA plus 55 incident diabetes cases and 110 age-
and sex-matched controls with normal glucose metabolism from KORA.
The studies were approved by the local ethics committees, and in-
formed written consent was obtained from the participants.
2.2. Blood samples
In the CARLA study non-fasting blood sampling was performed in
sitting position. Immediately after sampling, all serum and plasma
samples were centrifuged at 4 °C in-house by specially trained study.
The cooled samples were shipped to the Institute of Laboratory
Medicine, Clinical Chemistry and Molecular Diagnostics (ILM) at the
Leipzig University Clinics. For the analysis of HbA1c in EDTA antic-
oagulated blood, the High Performance Liquid Chromatography (HPLC)
method was used with the Variant II system (BIO-RAD, Munich,
Germany).
For KORA, blood was collected with minimal stasis, refrigerated at
4–8 °C, and shipped in refrigerant packaging within 2–4 h to the la-
boratory of Augsburg Central Hospital. Fasting venous blood glucose
was sampled in the morning (7:00 A.M. to 11:00 A.M.). HbA1c was
measured using a turbidimetric immunological method (Tinaquant;
Roche Diagnostics, Mannheim, Germany) with a Hitachi 717 analyser
in KORA S4 and with a reverse-phase cation-exchange high-perfor-
mance liquid chromatography (HPLC) method using the
Menarini–Arkray analyser HA-8160 (Menarini Diagnostics, Florence,
Italy) in KORA F4. Total cholesterol, high-density lipoprotein (HDL)
and triglycerides were measured by enzymatic methods (Roche
Diagnostics) (Rathmann et al., 2003).
2.3. Determination of POP concentrations
Using solid-phase extraction and gas chromatographic high-resolu-
tion mass spectrometry as described previously (Wittsiepe et al., 2014),
concentrations of the following six POPs were measured in baseline
serum samples stored at −80 °C for CARLA: polychlorinated biphenyl
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(PCB) 138, PCB-153, PCB-180, hexachlorobenzene (HCB), beta-hexa-
chlorocyclohexane (β-HCH), and 4,4′-dichlorodiphenyldi-
chloroethylene (4,4′-DDE). As not enough serum samples were avail-
able for KORA, we determined the same POPs in KORA S4 plasma
samples, which were stored at −70 °C until analysis. For 17 controls,
serum concentrations were also available. Based on these duplicates, we
conducted univariate linear regression to adjust the plasma con-
centrations.
2.4. Statistical analyses
Both confounding and mediating effects of blood lipids have been
suggested when investigating causal effects of POPs and type 2 diabetes
(Lee et al., 2014). However, there is still an ongoing debate how to best
approach this complex interplay methodologically. Since POPs are pre-
dominantly carried by blood lipids, lipid-standardized concentrations have
been suggested (initially to correct for differences in lipid concentrations
between fasting and non-fasting individuals) to reflect the body's POP-
burden better than wet-weight concentrations as (Lopez-Carrillo et al.,
1999). On the other hand, both experimental and epidemiological studies
have indicated that POPs can interfere with the lipid metabolism leading
to dyslipidemia, obesity and changes in metabolic phenotype (Yang et al.,
2017; Ruzzin et al., 2010; Lee et al., 2011b; Gasull et al., 2018). Being
involved in the pathological mechanisms to type 2 diabetes, lipid con-
centrations (and maybe even body mass index (BMI)) would thus re-
present intermediate factors through which POPs might cause diabetes
(Lee et al., 2014; Gasull et al., 2018) In this case, adjusting for lipid-levels
would underestimate the true associations between POP concentrations
and diabetes, whereas not adjusting for lipid levels would overestimate the
true associations (Lee et al., 2014) (similar methodological work has been
recently published for pancreatic cancer (Gasull et al., 2019)). Therefore,
we a priori decided to use the wet-weight concentrations (POPs con-
centrations in μg/l not divided by lipids) adjusting for total cholesterol and
BMI as our main analysis, but also present the results for lipid-standar-
dized concentrations (ng/g lipid) as has been suggested previously
(Lee et al., 2014).
To assess differences in baseline characteristics between cases and
controls within each cohort, we performed Pearsons's Chi-square test for
categorical variables and t-test for continuous variables. As POP con-
centrations strongly deviated from a normal distribution, we applied
Wilcoxon rank sum test to test for differences between cases and controls
but also between men and women separately for cases and controls of each
cohort. We used multivariable conditional logistic regression to assess the
association between serum POP concentrations and the odds of type 2
diabetes. A priori, we specified two multivariable models based on pre-
vious studies and availability of data in the two cohorts. The minimum
model included only an indicator variable for cohort (CARLA/KORA) as
age and sex were already adjusted for by design. The main model ad-
ditionally included baseline information on BMI (kg/m2), serum total
cholesterol (mmol/l), average alcohol consumption (g/d), smoking status
(current-, ex-, never-smoker), physical activity (regularly ≥1h/week vs.
unregularly/never), and parental diabetes (yes, no, unknown). Each POP
was then included in the regression model separately as a linear term. We
also applied two-pollutant models by adding a second POP variable if
Spearman's correlation coefficient was<0.7.
On an explorative basis, we investigated potential effect modifica-
tion by including interaction terms of the continuous POP concentra-
tions and: (i) the cohort indicator, since type 2 diabetes incidence was
different for Eastern and Western Germany (Schipf et al., 2014) but also
since the exposure to POPs might have been different due to the dif-
ferent living conditions; (ii) sex, since a higher susceptibility to POPs
has been reported for women in previous studies (Vasiliu et al., 2006;
Wang et al., 2008); (iii) obesity defined by BMI≥30 vs.< 30 kg/m2,
since POPs are stored in the adipose tissue (Lee et al., 2006; Everett
et al., 2007); and (iv) parental diabetes indicating potential differences
in the underlying baseline risk (Lee et al., 2014).
2.5. Sensitivity analyses
We conducted several sensitivity analyses to check the robustness of
our results. First, we left out total cholesterol as well as BMI since an
over-adjustment has been suggested if lipid levels are in the causal
pathway leading to an underestimation of the true association. (Lee
et al., 2014; Gasull et al., 2018; Gasull et al., 2019).
As an overestimation might also be the case if lipid levels are not
considered as well as to increase comparability with previous studies
(Lee et al., 2014), we also applied an extended confounder model ad-
justing for high-density lipoprotein cholesterol (mmol/l) instead of total
cholesterol and additionally for fasting triglycerides (mmol/l). As tri-
glycerides were not measured in 75 KORA participants (25 cases and 50
controls), we had to exclude these. For reasons of comparison, we also
reran the minimum and main model with the reduced data set
(N=320). In addition, also only feasible for the reduced data set, we
calculated lipid-standardized POP concentrations by dividing the serum
POP concentrations by the total serum lipid content according to the
Phillips formula (Phillips et al., 1989) and investigated the association
with type 2 diabetes adjusting for the minimum and main confounder
model (the latter without total cholesterol). Fourth, we conducted
stratified analyses since some fundamental differences between the two
cohorts existed, such as non-fasting (CARLA) vs fasting status (KORA),
or serum (CARLA) vs plasma (KORA) to measure the POPs. Fifth, we
excluded participants with extremely high POP concentrations identi-
fied based on visual inspection. Finally, we investigated the linearity
assumption of the dose-response function by incorporating each POP
separately as a smooth function (P-Spline with three degrees of
freedom).
All p-values were two-sided, and values< 0.05 were considered
statistically significant. All statistical analyses were performed with R




Mean follow-up time for CARLA was four years and seven years for
KORA. Table 1 presents the baseline characteristics and serum POP con-
centrations of the cases and controls stratified by cohort. There was an age
difference between the participants of the two cohorts, with an average
age of 63.4 ± 9.6 years in CARLA versus 54.5 ± 9.0 years in KORA.
Within both cohorts, the diabetes cases tended to have a higher BMI,
higher levels of HbA1c, lower HDL-cholesterol, and they more often re-
ported parental diabetes. Cases in KORA had higher serum concentrations
of PCB-153, HCB, and β-HCH than controls in KORA, whereas in CARLA
only higher β-HCH concentrations were observed in cases versus controls.
Comparing the two cohorts, PCB-138 and PCB-180 levels, as well as the
sum of the three PCBs, were considerably higher in KORA participants,
while PCB-153 concentrations were slightly higher in CARLA participants.
HCB, β-HCH and 4,4′-DDE showed much higher concentrations in CARLA
participants. A description of the reduced data set and the lipid-standar-
dized POP concentrations can be found in Supplementary Table S1. The
KORA participants were on average five years older than in the full KORA
sample and displayed slightly lower triglyceride levels but higher total
lipid concentrations than CARLA participants. For both cohorts, spearman
correlation coefficients indicated high correlations between the PCBs,
especially between PCB-138 and PCB-153 with a coefficient of 0.93 for
CARLA and 0.94 for KORA (Supplementary Table S2). The comparison of
internal POPs concentrations between women and men indicated higher
HCB and β-HCH levels for women compared to men for both cases and
controls of the CARLA cohort and for HCB for KORA cases and controls
(Supplementary Table S3). In both cohorts, PCB-180 concentrations were
increased in male controls compared to female controls.
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3.2. Regression models
Multivariable conditional logistic regression modeling showed that
serum POP concentrations were associated with an increased odds of
having incident diabetes (Table 2). Increased odds ratios (ORs) were ob-
served for PCB-138, PCB-153 and the sum of the three PCBs with higher
effect estimates for the main adjustment set compared to the minimum
model. Contrarily, for HCB the estimates decreased with the stricter ad-
justment and the association with diabetes was only significant in the
minimum adjustment model. For 4,4′-DDE, the association was also positive
though only borderline statistically significant and effect estimates re-
mained stable when adding additional covariates. We observed no evident
relationship between PCB-180 or β-HCH and incident diabetes. The two-
pollutant models showed mainly robust results (Supplementary Fig. S1).
Table 1
Baseline characteristics and POP concentrationsa of type 2 diabetes cases and controls (matched on age and sex) from the population-based cohort studies CARLA
(2002–2005) and KORA (1999–2001).
CARLA KORA
Baseline characteristics Cases Controls Cases Controls
Mean ± SD or N (%) Mean ± SD or N (%)
N 77 154 55 110
Age (years) 63.4 ± 9.6 63.4 ± 9.5 55.1 ± 8.8 54.2 ± 9.2
Sex (male) 46 (59.7) 92 (59.7) 33 (60) 66 (60)
HbA1c (%) 5.9 ± 0.4 5.5 ± 0.4⁎ 5.8 ± 0.3 5.3 ± 0.3⁎
HbA1c (mmol/mol) 41 ± 4.4 37 ± 4.4 40 ± 3.3 34 ± 3.3
BMI (kg/m2) 29.9 ± 5.4 27.4 ± 4.1⁎ 31.2 ± 4.2 26.8 ± 4⁎
Cholesterol (mmol/l) 5.3 ± 1 5.6 ± 1.1⁎ 6.2 ± 1.3 6 ± 1
HDL (mmol/l) 1.3 ± 0.4 1.5 ± 0.4⁎ 1.3 ± 0.4 1.5 ± 0.4⁎
Alcohol (g/day) 11.6 ± 17.9 13.6 ± 17.6 28.8 ± 37.6 20.3 ± 19.9
Physical activity (regular≥1 h/week) 25 (32.5) 70 (45.5) 28 (50.9) 74 (67.3)
Parental diabetes
Yes 24 (31.2) 35 (22.7) 24 (43.6) 23 (21.1)⁎
No 37 (48.1) 88 (57.1) 21 (38.2) 72 (66.1)
Unknown 16 (20.8) 31 (20.1) 10 (18.2) 14 (12.8)
Smoking status
Current 18 (23.4) 20 (13) 11 (20) 26 (23.6)
Ex 28 (36.4) 68 (44.2) 22 (40) 47 (42.7)
Never 31 (40.3) 66 (42.9) 22 (40) 37 (33.6)
POPs (μg/l) Median (Q1-Q3) Median (Q1-Q3)
PCB-138 0.51 (0.39–0.79) 0.48 (0.33–0.66) 1.47 (1.17–1.86) 1.36 (0.99–1.76)
PCB-153 0.93 (0.70–1.35) 0.94 (0.68–1.26) 0.86 (0.59–1.09) 0.70 (0.50–0.92)†
PCB-180 0.77 (0.57–1.07) 0.79 (0.63–1.11) 1.21 (0.95–1.67) 1.23 (0.89–1.60)
Sum of PCBs 138, 153, 180 2.17 (1.62–3.19) 2.22 (1.65–2.97) 3.66 (2.76–4.46) 3.29 (2.42–4.26)
HCB 1.02 (0.56–1.55) 0.77 (0.46–1.32) 0.59 (0.24–1.08) 0.39 (0.27–0.64)†
β-HCH 0.47 (0.32–0.66) 0.40 (0.23–0.63)† 0.24 (0.15–0.37) 0.19 (0.14–0.31)†
4,4′-DDE 6.82 (3.45–13.9) 6.25 (3.22–11.47) 2.83 (1.56–5.28) 1.89 (1.20–3.46)
N: total number; BMI: body mass index; HDL: high-density lipoprotein; SD: standard deviation; POPs: persistent organic pollutants; PCB: polychlorinated biphenyl;
HCB: hexachlorobenzene; β-HCH: beta-hexachlorocyclohexane; 4,4′-DDE: 4,4′-dichlorodiphenyldichloroethylene; Q1, Q3: first and third quartile.
a POP concentrations were measured in serum for CARLA and plasma in KORA which were subsequently calibrated based on 17 duplicates.
⁎ p-value< 0.05 for comparison between cases and controls within each cohort: Pearson's Chi-square test for categorical variables and t-test for continuous
variables.
† p-value< 0.05 of Wilcoxon rank sum test for comparison between cases and controls within each cohort.
Table 2
Associations between POP concentrations (per interquartile increase) and incident type 2 diabetes within the population-based cohort studies CARLA (2002−2013)
and KORA (1999–2008) – full sample (N=395a; 132 cases and 263 controls).






Model without BMI & cholesterole
OR (95% CI)
PCB-138 0.8 1.34 (1.00, 1.78)⁎ 1.50 (1.07, 2.11)⁎ 1.36 (0.98;1.88) 1.33 (0.98;1.81)
PCB-153 0.6 1.32 (1.04, 1.67)⁎ 1.53 (1.15, 2.04)⁎ 1.38 (1.06;1.80)⁎ 1.32 (1.03;1.70)⁎
PCB-180 0.6 1.00 (0.86, 1.15) 1.08 (0.93, 1.26) 1.06 (0.91;1.23) 1.01 (0.87;1.17)
Sum of PCBs 138, 153, 180 1.8 1.14 (0.93, 1.40) 1.29 (1.01, 1.64)⁎ 1.21 (0.96;1.51) 1.15 (0.93;1.42)
HCB 0.8 1.43 (1.12, 1.84)⁎ 1.22 (0.93, 1.59) 1.17 (0.91;1.52) 1.42 (1.11;1.82)⁎
β-HCH 0.3 1.00 (0.94, 1.07) 1.00 (0.93, 1.08) 1.00 (0.93;1.08) 1.00 (0.94;1.07)
4,4′-DDE 6.9 1.21 (0.99, 1.48) 1.22 (0.99, 1.49) 1.18 (0.98;1.43) 1.22 (1.00;1.48)⁎
POPs: persistent organic pollutants; PCB: polychlorinated biphenyl; HCB: hexachlorobenzene; β-HCH: beta-hexachlorocyclohexane; 4,4′-DDE: 4,4′-di-
chlorodiphenyldichloroethylene; IQR: interquartile range; OR: odds ratio; CI: confidence interval.
a One control had to be excluded due to missing information on parental diabetes.
b Multivariable conditional logistic regression analysis adjusted for cohort (CARLA/KORA) only.
c Multivariable conditional logistic regression analysis adjusted for cohort, body mass index, total cholesterol levels, alcohol consumption, smoking status, physical
activity , and parental diabetes.
d Main model without adjustment for total cholesterol levels.
e Main model without adjustment for total cholesterol levels and body mass index.
⁎ p-value < 0.05.
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3.3. Effect modification
The explorative investigation of effect modification by the inclusion
of interaction terms indicated higher effect estimates for females for
most POPs except HCB compared to males though the interaction terms
were not statistical significant (Fig. 1). Non-obese participants showed a
positive association of PCB-153, HCB and 4,4′-DDE with diabetes
whereas no association was observed for these POPs for obese partici-
pants (Fig. 1). No clear pattern was observed for an effect modification
by parental diabetes (Supplementary Fig. S1). The KORA cohort
showed a significantly increased OR for PCB-153 and HCB but inter-
action terms for the cohort indicator were not significant (Supple-
mentary Fig. S2).
3.4. Sensitivity analyses
Not adjusting for total cholesterol led to slightly decreased effect
estimates compared to the main adjustment set (Table 2). When leaving
out BMI as well, the effect sizes were similar to the minimal adjustment
set indicating that the other covariates did not affect the POPs-diabetes
associations (Table 2). Both, the model with extended confounder
control adjusting for high-density lipoprotein cholesterol and trigly-
cerides and the model with lipid-standardized POP concentrations
showed largely reduced effect sizes without significant associations
(Supplementary Table S4 and Table 3). Except for 4,4′-DDE, the
minimum and main adjustment model for the reduced data set
(Supplementary Table S4) resulted, however, in similar though slightly
lower odds compared to the main results implicating that the reduced
number of observations is not responsible for the decreased effect size
but the more stringent lipid adjustment. The stratified analyses showed
significant positive odds for PCB-138, PCB-153, β-HCH and 4,4′-DDE
for CARLA whereas no significant associations were seen for KORA in
the full sample (Supplementary Table S5). Our main results did not
change when excluding three cases and three controls with extremely
high POP concentrations (data not shown). The investigation of the
dose-response function by including the POP concentrations as smooth
functions indicated no deviation from linearity (Supplementary Fig.
S3).
4. Discussion
In this first population-based nested case-control study on POP ex-
posure and type 2 diabetes in Germany, we have found a positive as-
sociation between serum PCB-138 and PCB-153 concentrations and
incident type 2 diabetes. In addition, our results indicated a higher odds
for the total sum of the three PCB and 4,4′-DDE. The effects were mostly
more pronounced in females. These results are in overall agreement
with findings from a limited number of prospective studies that have
reported associations between some POPs, or combinations of POPs,
and incident diabetes (Wu et al., 2013; Lee et al., 2011a; Lee et al.,
2010; Rignell-Hydbom et al., 2009; Turyk et al., 2009; Vasiliu et al.,
2006; Wang et al., 2008; Grice et al., 2017; Zong et al., 2018; Turyk
et al., 2015). Findings for individual POPs, however, were not con-
sistent across the studies. Since the methods and especially the pre-
sentation of results differed a lot among the studies, precluding direct
comparison of the effect estimates, the following comparison is quali-
tative in nature.
The PCBs analyzed in this study (PCB-138, PCB-153 and PCB-180)
were all higher chlorinated PCBs which reflect long-term contamination
mainly through food as they decompose very slowly and accumulate
strongly in organisms and the food chain (UBA and German
Environment Agency, 2018). PCBs were previously used as hydraulic
fluids, insulating and cooling liquids, plasticizers and flame retardants
but are also substantially emitted as by-products of thermal processes.
Only one study from Sweden among seniors (Lee et al., 2011a) and
another study from the US among two female subcohorts (Wu et al.,
2013) investigated PCB-138 separately. However, while we saw a clear
relationship with incident diabetes, the Swedish study reported a po-
sitive but non-significant association, whereas the two US cohorts
Fig. 1. Adjusted odds ratios (OR) with 95%-confidence intervals for the asso-
ciation of POP concentrations and incident type 2 diabetes (T2D): effect mod-
ification by sex (top; black circles= Females; white squares=Males) and
obesity (bottom; black circles=No (BMI < 30 kg/m2); white squares=Yes
(BMI≥ 30)). All models were adjusted for cohort, body mass index, total
cholesterol, alcohol consumption, smoking status, physical activity, and par-
ental diabetes (main model). POP: persistent organic pollutant; PCB: poly-
chlorinated biphenyl; PCB-sum: sum of PCBs 138, 153, 180; HCB: hexa-
chlorobenzene; β-HCH: beta-hexachlorocyclohexane; 4,4′-DDE: 4,4′-
dichlorodiphenyldichloroethylene.
Table 3
Associations between lipid-standardized POP concentrations (per interquartile
increase) and incident type 2 diabetes, reduced data set (N=320; 107 cases
and 213 controls).




PCB-138 102 1.02 (0.73;1.43) 1.04 (0.73;1.49)
PCB-153 72 1.04 (0.79;1.36) 1.14 (0.85;1.54)
PCB-180 79 0.88 (0.70;1.10) 0.96 (0.81;1.15)
Sum of PCBs 138, 153, 180 228 0.93 (0.73;1.19) 1.01 (0.79;1.28)
HCB 123 1.22 (0.96;1.56) 1.06 (0.80;1.39)
β-HCH 46 1.01 (0.94;1.09) 1.00 (0.91;1.08)
4,4′-DDE 1089 1.19 (0.93;1.52) 1.17 (0.90;1.52)
POPs: persistent organic pollutants; PCB: polychlorinated biphenyl; HCB: hex-
achlorobenzene; β-HCH: beta-hexachlorocyclohexane; 4,4′-DDE: 4,4′-di-
chlorodiphenyldichloroethylene; IQR: interquartile range; OR: odds ratio; CI:
confidence interval.
a Multivariable conditional logistic regression analysis adjusted for cohort
(CARLA/KORA).
b Multivariable conditional logistic regression analysis adjusted for cohort,
body mass index, alcohol consumption, smoking status, physical activity , and
parental diabetes but not total cholesterol.
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pointed to no association at all. PCB-153 was additionally examined in
two case-control studies from the US among African Americans and
Whites (Lee et al., 2010) as well as American Indians (Grice et al., 2017)
and one case-control study among Swedish women (Rignell-Hydbom
et al., 2009). None of them found an association with diabetes, whereas
the above mentioned studies (Wu et al., 2013; Lee et al., 2011a) and our
study suggested an increased risk. For PCB-180, the Swedish seniors
showed a highly increased risk which is not supported by other studies
(Wu et al., 2013; Lee et al., 2011a; Lee et al., 2010; Grice et al., 2017;
Turyk et al., 2015) including our results. Previous studies also sug-
gested to analyze the sum of PCBs as well as selected groupings of PCB
congeners either based on biological characteristics or previous findings
(Lee et al., 2010; Zong et al., 2018). We therefore additionally analyzed
the sum of the three PCBs available for our studies, although we were
aware that the respective sum estimates cannot be directly compared to
the sum estimates of other PCB combinations as has been shown pre-
viously (Lee et al., 2010). Studies with a similar grouping reported
positive but non-significant associations (Wu et al., 2013; Lee et al.,
2010; Zong et al., 2018).
HCB is a fungicide but was also used as flame retardant and plas-
ticizer and is emitted substantially by thermal processes (UBA and
German Environment Agency, 2018). Due to its comparatively high
vapor pressure it is very mobile in the environment. While previous
studies reported a significantly decreased risk (Grice et al., 2017) or no
association (Lee et al., 2010; Zong et al., 2018), others observed an
increased risk (Wu et al., 2013) or at least an indication for an increased
risk (Lee et al., 2011a) similar to our results. β-HCH is an isomeric
compound among the group of chlorinated hydrocarbons and a by-
product of the production of the insecticide lindane (γ-HCH). Similar to
our results, previous studies did not see an association for this POP with
type 2 diabetes (Lee et al., 2010; Grice et al., 2017; Zong et al., 2018).
4,4′-DDE is the main metabolite of dichlorodiphenyltrichloroethane
(DDT) and even more persistent than DDT (UBA and German
Environment Agency, 2018). Our results indicated a positive associa-
tion robust for confounder adjustment, which was also seen by others
(Turyk et al., 2009; Zong et al., 2018; Turyk et al., 2015). However,
there are also other investigations who did not observe an association
(Lee et al., 2010; Rignell-Hydbom et al., 2009; Grice et al., 2017; Zong
et al., 2018).
Differences in population characteristics, POP exposure distribu-
tions, outcome ascertainment, covariate adjustment, and the varying
laboratory and analytical approaches may partly explain these incon-
sistencies. A further issue of discussion is how to methodologically
approach the complex interplay between blood lipids, fasting status,
and body mass index when estimating possible causal effects of POPs
since both confounding and mediating effects have been suggested (Lee
et al., 2014; Gasull et al., 2019). Among the prospective studies on POP
exposure and risk of diabetes, two studies (Wu et al., 2013; Zong et al.,
2018) used lipid-standardized POP concentrations as opposed to ten
(Lee et al., 2011a; Lee et al., 2010; Rignell-Hydbom et al., 2009; Turyk
et al., 2009; Vasiliu et al., 2006; Wang et al., 2008; Grice et al., 2017;
Turyk et al., 2015) that used wet-weight POP concentrations, of which
five adjusted the applied statistical models for serum lipid levels (Lee
et al., 2011a; Lee et al., 2010; Turyk et al., 2009; Grice et al., 2017;
Turyk et al., 2015). Since lipid-standardized concentrations have been
initially suggested to correct for differences in lipid concentrations
between fasting and non-fasting individuals (Phillips et al., 1989) and
fasting status was indirectly a matching factor in our study (CARLA
participants were non-fasting whereas KORA participants were fasting),
we a priori decided to mainly focus on wet-weight concentrations but
also to conduct several sensitivity analyses in terms of lipid and BMI
adjustment. Interestingly, our effect estimates slightly decreased when
we did not adjust for total cholesterol and BMI compared to the main
adjustment set. When additionally adjusting for triglycerides or in-
vestigating lipid-standardized POP concentrations which were however
only available for a subgroup of participants, all associations between
serum POP levels and risk of diabetes disappeared. Nevertheless, the
reduced sample size seemed not to be responsible for the decrease in
effect size. In contrary, a recent matched case-control study among 793
pairs of middle aged (mean: 45 years) US women reported significant
positive associations of HCB, β-HCH, p,p′-DDE and dioxin-like PCBs on
type 2 diabetes with similar effect sizes for wet-weight and lipid-stan-
dardized POP concentrations though the latter decreased considerably
and turned mostly non-significant when additionally adjusted for BMI
(Zong et al., 2018). Interestingly, all of the mutually investigated
plasma POP concentrations were much lower compared to the serum
concentrations of our study participants, with e.g. lipid-standardized
median concentrations for cases of 39 ng/g lipid for PCB-153 and
18 ng/g lipid for HCB compared to 132 and 122 ng/g lipid for PCB-153
and 142 and 70 ng/g lipid for HCB for CARLA and KORA, respectively.
Our duplicate measurements indicated slightly lower plasma than
serum POP concentrations and correction factors for KORA samples
ranged from 1.10 for HCB to 1.26 for PCB-180 with intercepts of 0.0 for
β-HCH to 0.08 for PCB-138 (R2 of 0.87 for HCB to 0.99 for β-HCH and
4,4′-DDE). Another case-control study from the US pooling two female
subcohorts observed mostly positive but non-significant associations
between several POPs (also measured in plasma) and type 2 diabetes
which were in general slightly stronger pronounced when using wet-
weight concentrations adjusting for total cholesterol and triglycerides
than lipid-standardized levels (Wu et al., 2013). Lipid-standardized
median levels of PCB-153 with 117 and 98 ng/g lipid among partici-
pants with incident diabetes of the two cohorts were actually quite si-
milar to the concentrations we observed in our KORA participants
whereas HCB levels were also much lower with 34 and 41 ng/g lipid.
Since wet-weight concentrations are partly not stated (Wu et al., 2013)
or reported in quartiles (Lee et al., 2010; Vasiliu et al., 2006), quintiles
(Lee et al., 2011a) or as geometric mean (Turyk et al., 2009; Wang
et al., 2008; Grice et al., 2017; Turyk et al., 2015). However, a recent
multi-center study on methodological issues of plasma POP con-
centrations and pancreatic cancer risk reported huge differences in wet-
weight concentrations from 1533 participants aged 35–70 years old for
the eight study regions (Gasull et al., 2019). For example, median
plasma PCB-153 levels ranged from 0.34 μg/l in Greece to 1.35 μg/l in
Germany, including our median serum concentrations of 0.93 and
0.89 μg/l for CARLA and KORA cases. Median plasma HCB levels
ranged from 0.24 μg/l in participants from the UK to 4.40 μg/l in par-
ticipants from Spain, also covering our median serum levels of 1.02 and
0.59 μg/l for CARLA and KORA cases. Also, the other POPs con-
centrations of our cohorts lay within the ranges reported for the eight
countries except for PCB-138 in KORA cases with a median level of
1.47 μg/l compared to median plasma levels of 0.22 in Greece to
0.87 μg/l in Sweden.
The investigation of effect modifications by the inclusion of inter-
action terms has to be treated with caution and should rather serve as
an indication since inference is limited due to the small samples size.
Our results suggested an increased risk for women which has also been
reported for stratified analyses of total PCB for a highly exposed US
cohort (Vasiliu et al., 2006) and a Taiwanese study (Wang et al., 2008),
whereas a study among US fish consumers reported no evidence for an
effect modification by sex for total PCB or 4,4′-DDE (Turyk et al., 2009).
Furthermore, our results indicated a higher risk for non-obese partici-
pants for some of the POPs. Contrary, previous studies observed an
association only in obese participants for PCBs (Lee et al., 2010) or 4,4′-
DDE (Turyk et al., 2009) while no effect modification by obesity was
seen in Swedish seniors (Lee et al., 2011a) or middle aged US women
(Zong et al., 2018). Regional differences in diabetes incidence have
been described for Germany with highest rates in the East (16.9% (95%
CI: 13.3–21.8%) per 1000 person years) and lowest rates in the South
(9.3% (95% CI: 7.4–11.1%) per 1000 person years) (Schipf et al., 2014).
Since this variation could only partly be explained by regional differ-
ences in common risk factors for type 2 diabetes, including age, sex,
BMI and socioeconomic status, we hypothesized that the degree of POP
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exposure might also play a role due to differences in regulation and
handling between the former German Democratic Republic (East Ger-
many) and the Federal Republic of Germany (West Germany). Indeed,
with the exception of PCB-138, PCB-180 and the sum of PCBs 138, 153
and 180, participants from CARLA (representing the northeast German
population) showed higher POP concentrations compared to partici-
pants from KORA (representing the Southwestern German population).
However, we did not observe a clear pattern indicating an effect
modification of the observed associations by cohort.
The main strengths of this study include the prospective study de-
sign, the use of incident diabetes cases and the selection of cases and
controls from population-based cohort studies permitting general-
izability of our results to the general population. Some limitations need
to be considered as well. First, the study sample is relatively small,
resulting in limited statistical power. Especially the inspection of effect
modifications should be regarded as rather exploratory. Second, POP
concentrations from KORA participants were assessed in plasma sam-
ples. We converted these plasma values to serum values based on uni-
variate linear regression models of 17 duplicate samples. Third, while
we observed associations with development of diabetes for PCB-138
and PCB-153, it might be that these associations are attributable to
other unmeasured POP subclasses like dioxins or organochlorine pes-
ticides. During the entire lifetime, people are exposed to a mixture of
several hundred POPs with various distributions. Given the correlations
between POPs, and the large array of POPs in background exposure,
patients with low levels of a specific POP likely also have higher levels
of other POPs (Porta et al., 2012). Therefore, one specific POP may
partly reflect the influence of other POPs rather than that of itself, and
caution should be taken not to over-interpret findings for single POPs.
In addition, we could also not consider chemical mixtures of rather new
toxicants like brominated flame retardants, perfluoroalkyl and poly-
fluoroalkyl substances, phthalates, or bisphenols for which diabeto-
genic effects have been suggested and which might be correlated with
POPs as well due to mixing in the environment and food chain (Lind
and Lind, 2018).
5. Conclusions
In conclusion, our results support a positive association between
POP exposure and development of type 2 diabetes. However, larger
longitudinal studies are needed to gain further insights into the (dose-
dependent) effect of POPs on diabetes. Preferably, studies using real-
world populations are required that not only consider exposure to a
broad range of POPs, but also other types of diabetogenic environ-
mental pollutants and chemicals to study additive or even multi-
plicative interactions between the various substances. Furthermore,
serial POP measurements are recommended over single measurement,
since serum POP levels fluctuate with fluctuating body weight. Serial
measurements may also shed further light on the complex interactions
that have been suggested between POPs and obesity. In addition, there
is a clear need for several agents to become more aware of and active on
the available evidence on the environmental causes of type 2 diabetes.
Therefore, policy-makers (in public institutions and private companies),
citizens, clinicians, and the media need to act effectively and in joint
efforts to reduce the environmental burden of disease.
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